Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death

R Zachariah1, M P Spielmann, A D Harries

  • 1Médecins Sans Frontières-Luxembourg, Thyolo District, Malawi. zachariah@internet.lu

Insights

Malnutrition significantly increases early mortality risk in tuberculosis patients in Malawi. Patients with moderate to severe malnutrition (BMI < 17.0 kg/m2) faced a higher chance of death within four weeks of treatment.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Nutritional Science

Background:

  • Tuberculosis (TB) remains a major global health challenge, particularly in low-income countries.
  • Malnutrition is a common comorbidity in TB patients, potentially impacting treatment outcomes.
  • High rates of human immunodeficiency virus (HIV) infection coexist with TB, further complicating patient management.

Purpose of the Study:

  • To determine the prevalence of malnutrition among new TB patients in rural Malawi.
  • To investigate the association between malnutrition and early mortality (within 4 weeks of treatment) in this population.

Main Methods:

  • A cohort study was conducted involving 1181 new TB patients in Malawi.
  • Nutritional status was assessed using body mass index (BMI) on admission.
  • Data on patient demographics, HIV status, and mortality within the first 4 weeks of treatment were collected and analyzed.

Main Results:

  • 57% of TB patients were malnourished (BMI < 18.5 kg/m2) on admission.
  • Severe malnutrition (BMI < 15.9 kg/m2) was prevalent in 21% of patients.
  • Early mortality occurred in 8% of patients, with increasing malnutrition severity, age over 35, and HIV seropositivity identified as significant risk factors.

Conclusions:

  • Malnutrition is highly prevalent in TB patients in Malawi and is significantly associated with increased early mortality.
  • A BMI < 17.0 kg/m2 was linked to a greater risk of death within the first four weeks of TB treatment.
  • Addressing malnutrition is crucial for improving treatment outcomes and reducing mortality in TB patients, especially in high HIV prevalence settings.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...